No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
James Januzzi, MD
Martin Maron, MD
- ACC.24
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Akshay S. Desai, MD
Erik Stroes, MD, PhD
